Ian Pearce
Overview
Explore the profile of Ian Pearce including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
912
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mubarak M, Isa Q, Hayes J, Pearce I, Modgil V
Int J Impot Res
. 2025 Mar;
PMID: 40075165
Penoscrotal decompression (PSD) has emerged as a promising surgical intervention for refractory ischaemic priapism, involving proximal corporotomies and the drainage of ischaemic blood. Initial outcomes have shown high success rates...
2.
Chandak S, Gurudas S, Pakeer R, Kazantzis D, Ghanchi F, Grabowska A, et al.
Eye (Lond)
. 2025 Feb;
PMID: 39984700
Purpose: To identify demographic and baseline OCT characteristics that are predictive of VA outcomes after the first and post-loading injections in patients treated with 2 mg aflibercept. Methods: This study...
3.
Mubarak M, Isa Q, Modgil V, Pearce I
Int J Impot Res
. 2025 Jan;
PMID: 39870913
The ejaculatory reflex consists of emission and expulsion, with the latter involving rhythmic muscular contractions that propel seminal fluid. Botulinum toxin, through its inhibitory effects, has been hypothesized to improve...
4.
Heier J, Lad E, Holz F, Rosenfeld P, Guymer R, Boyer D, et al.
Immunotherapy
. 2025 Jan;
1-15.
PMID: 39819346
No abstract available.
5.
Hammad M, Barham D, Simhan J, Nguyen T, Swerdloff D, Miller J, et al.
J Sex Med
. 2024 Dec;
22(2):349-355.
PMID: 39724925
Background: Inflatable penile prosthesis (IPP) insertion is recommended for the treatment of patients with Peyronie's disease (PD) and significant erectile dysfunction (ED); adjunctive procedures can be used for residual curvature...
6.
Loewenstein A, Sylvanowicz M, Amoaku W, Aslam T, Cheung C, Eldem B, et al.
Ophthalmol Ther
. 2024 Dec;
14(1):211-228.
PMID: 39673040
Introduction: Neovascular age-related macular degeneration is a global public-health concern, associated with a considerable burden to individuals, healthcare systems, and society. The objective of this study was to understand different...
7.
Ziemssen F, Sylvanowicz M, Amoaku W, Aslam T, Eldem B, Finger R, et al.
Ophthalmol Ther
. 2024 Dec;
14(1):229-246.
PMID: 39673039
Introduction: In contrast with patients receiving therapy for retinal disease during clinical trials, those treated in routine clinical practice experience various challenges (including administrative, clinic, social, and patient-related factors) that...
8.
Chang C, Barham D, Dalimov Z, Swerdloff D, Sadeghi-Nejad H, Andrianne R, et al.
BJU Int
. 2024 Dec;
135(3):528-534.
PMID: 39658322
Objectives: To evaluate the pre- and intraoperative variables that impact the integrity of the corporal bodies over time after inflatable penile prosthesis (IPP) placement, as predictors of intraoperative corporal perforation...
9.
Narendran N, Bailey C, Downey L, Gale R, Kotagiri A, Pearce I, et al.
Clin Ophthalmol
. 2024 Nov;
18:3133-3142.
PMID: 39512482
Purpose: The inclusion of ranibizumab biosimilars into National Health Service England commissioning recommendations published in 2022 created a need for expert guidance to optimize treatment outcomes in patients with neovascular...
10.
Teo K, Eldem B, Joussen A, Koh A, Korobelnik J, Li X, et al.
Eye (Lond)
. 2024 Oct;
PMID: 39379523
Practice patterns for neovascular age-related macular degeneration (nAMD) have evolved from the landmark registration trials of vascular endothelial growth factor (VEGF) inhibitors. Non-monthly regimens like treat-and-extend (T&E) have become popular...